StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
301108.SZ$24.43+6.73%
Fair $24.43+0.0%

301108.SZ

Tongling Jieya Biologic Technology Co., Ltd.

Consumer Defensive / Household & Personal ProductsShenzhen

$24.43

+1.54 (+6.73%)

Fairly Valued+0.0%Fair Value $24.43Fund rank 25/100 · Data gapFallback financials|
SA 45/C
F-Score: 7/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-21.1M · quality 43.7/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 9/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

45/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 4.1%, below the 5% threshold
Thesis & Journal · 301108.SZLocal privado en este navegador · Tongling Jieya Biologic Technology Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2.7B

P/E

38.2x

↑

EV/EBITDA

15.4x

↑

ROE

4.1%

↓

Gross Margin

25.4%

↓

Debt/Equity

0.02

↓
52-Week Range$24
$22$41

TradingView lightweight chart

301108.SZ price, volumen y niveles de valoración

Último $24.43Periodo -70.5%
Fair value: $24.43

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+5.0%

FCF CAGR

—

FCF margin

-34.8%

FCF / Net income

-3.48x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $772.0M · net income $77.3M · FCF $-268.8M

2022-FY → 2025-FY

Gross margin

25.4%-6.0% pts

Operating margin

13.1%-8.8% pts

Net margin

10.0%-11.1% pts

FCF margin

-34.8%-75.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$772.0M$772.0M$547.5M$622.6M$666.6M
Net Income$77.3M$77.3M$19.5M$115.2M$141.0M
EBITDA$139.8M$139.8M$72.7M$175.1M$198.4M
EPS0.680.680.171.011.24
Gross Margin25.4%25.4%19.6%29.6%31.5%
Operating Margin13.1%13.1%5.9%17.0%21.9%
Net Margin10.0%10.0%3.6%18.5%21.1%
Balance Sheet
Debt/Equity0.020.020.000.010.02
Current Ratio3.663.66———
Cash Flow
Free Cash Flow$-268.8M$-268.8M$-21.1M$-1.5M$269.1M
Returns
ROE4.1%4.1%1.1%6.2%7.9%
Valuation
P/E38.1738.17139.5934.3327.77
EV/EBITDA15.4415.4431.9518.8914.82
P/B1.481.481.492.132.20
Growth & Yield
Revenue Growth41.0%41.0%-12.1%-6.6%—
EPS Growth300.0%300.0%-83.2%-18.4%—
Dividend Yield1.3%1.3%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

47.2%

muy exigente

EPS terminal req.

$2.17

Spread vs growth

252.8%

5Y implied EPS CAGR

31.0%

muy exigente

EPS terminal req.

$2.62

Spread vs growth

269.0%

10Y implied EPS CAGR

20.0%

exigente

EPS terminal req.

$4.22

Spread vs growth

280.0%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -22.3%

Total return

-22.3%

Start / end P/E

188.2x → 35.9x

EPS bridge

0.17 → 0.68

Residual

-242.7%

EPS growth+300.0%
Multiple rerating-80.9%
Dividend+1.3%
Residual / FX / buybacks / cross-term-242.7%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.